Is there a role of miRNA -330-3p and miRNA-362-3p in Lupus Nephritis?
The Egyptian journal of Immunology · 2025
DOI: 10.55133/eji.320405 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Egyptian journal of Immunology, 2025. Verfasst von Mohamed F A Assar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Biochemistry Division, Faculty of Science, Menoufia University, Menoufia, Egypt. Hauptthemen laut MEDLINE: Lupus Nephritis, MicroRNAs, Lupus Erythematosus, Systemic.
Abstract (Originalsprache)
Systemic lupus erythematosus (SLE) is an autoimmune disease, with lupus nephritis (LN) being one of its most serious complications. MicroRNAs, particularly miRNA-330-3p and miRNA-362-3p, were implicated in immune regulation and inflammation. This study aimed to evaluate the potential role of miRNA-330-3p and miRNA-362-3p in the progression of SLE and LN. This cross-sectional study included 150 participants: 50 controls (Group I), 50 SLE patients without nephritis (Group II), and 50 patients with lupus nephritis (Group III). Serum levels of miRNA-330-3p and miRNA-362-3p were quantified using a real-time polymerase chain reaction (PCR) test. Clinical and laboratory parameters were assessed, including disease activity and nephritis classification. miRNA-330-3p levels were significantly lower in both patients without nephritis (1.119 ± 1.289) and patients with nephritis (0.89 ± 0.518) compared to controls (1.312 ± 0.480; p < 0.001). miRNA-362-3p levels were significantly lower in patients with nephritis (0.623 ± 0.925) than in both controls (1.268 ± 0.419; p < 0.001) and patients without nephritis (1.254 ± 1.351; p < 0.001). The receiver operating characteristic (ROC) curve analysis revealed that miRNA-362-3p discriminated LN from non-LN SLE patients (AUC = 0.754; cut off ≤ 0.204; sensitivity 66%, specificity 72%). Both miRNA-330-3p and miRNA-362-3p are down regulated in SLE, particularly in patients with LN. These miRNAs may represent therapeutic targets, pending validation in future studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Biochemistry Division, Faculty of Science, Menoufia University, Menoufia, Egypt.
- Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Menoufia University, Menoufia, Egypt.
- Department of Internal Medicine, Nephrology Unit, Faculty of Medicine, Menoufia University, Menoufia, Egypt.
Zitieren
APA
Assar, M. F. A., Badr, E. A., Toulan, S. O., Elhalafawy, A. N. I., & Mostafa, B. A. (2025). Is there a role of miRNA -330-3p and miRNA-362-3p in Lupus Nephritis?. The Egyptian journal of Immunology. https://doi.org/10.55133/eji.320405
Vancouver
Assar MFA, Badr EA, Toulan SO, Elhalafawy ANI, Mostafa BA. Is there a role of miRNA -330-3p and miRNA-362-3p in Lupus Nephritis?. The Egyptian journal of Immunology. 2025. doi:10.55133/eji.320405
BibTeX
@article{Assar2025,
author = {Assar, Mohamed F A and Badr, Eman A and Toulan, Safwa O and Elhalafawy, Ashwak N I and Mostafa, Basma A},
title = {Is there a role of miRNA -330-3p and miRNA-362-3p in Lupus Nephritis?},
journal = {The Egyptian journal of Immunology},
year = {2025},
doi = {10.55133/eji.320405}
}
EUVIMED